No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
U.S. Healthcare Spending Climbs 7.5% in 2023
Investors in Surgery Partners (NASDAQ:SGRY) Have Unfortunately Lost 53% Over the Last Three Years
Worst Performing Stocks for Tax Loss Selling – Wolfe
BofA Securities Initiates Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $30
JPMorgan Adjusts Surgery Partners Price Target to $28 From $38, Maintains Neutral Rating
Surgery Partners, Inc. (NASDAQ:SGRY) Is Expected To Breakeven In The Near Future